The effect of potassium citrate on overactive bladder disease: A cross-sectional study

Basit Öğe Kaydı
dc.contributor.authorUçar, Murat
dc.contributor.authorAkkoç, Ali
dc.contributor.authorTopçuoğlu, Murat
dc.contributor.authorÖzturk, Sefa Alperen
dc.contributor.authorDemir, Murat
dc.date.accessioned2021-02-19T21:16:08Z
dc.date.available2021-02-19T21:16:08Z
dc.date.issued2020
dc.departmentALKÜ
dc.description.abstractObjective: To show the effect of potassium citrate treatment on overactive bladder disease in patients with kidney stone and overactive bladder symptoms. Study Design: Experimental study. Place and Duration of Study: Department of Urology, Alanya Alaaddin Keykubat University and Department of Urology, Suleyman Demirel University, Turkey, from October 2019 to July 2020. Methodology: Patients with an indication for starting potassium citrate therapy because of kidney stone, and patients with symptoms of overactive bladder disease were included in the study. At the beginning of the treatment, the overactive bladder-version 8 form was filled and potassium citrate 10 meq 2x2 dose was started to the patients. The effect of potassium citrate on the symptoms of overactive bladder disease was demonstrated by filling the overactive bladder-version 8 form after one month of treatment. Results: A total of 82 people, 36 men and 46 women, participated in the study. Potassium citrate treatment caused a significant increase in urine pH levels (p<0.001). After potassium citrate treatment, there was a significant decrease in the score of the overactive bladder-version 8 form. (p<0.001). A positive correlation was found between age and overactive bladder-version 8 score change (p = 0.004). Conclusion: Potassium citrate can be used in the treatment of overactive bladder disease. The effect of potassium citrate treatment on ameliorating overactive bladder symptoms is more distinct in elderly patients.
dc.identifier.doi10.29271/jcpsp.2020.12.1301
dc.identifier.endpage1305en_US
dc.identifier.issn1022-386X
dc.identifier.issn1681-7168
dc.identifier.issue12en_US
dc.identifier.pmid33397057
dc.identifier.scopusqualityQ2
dc.identifier.startpage1301en_US
dc.identifier.urihttps://doi.org/10.29271/jcpsp.2020.12.1301
dc.identifier.urihttps://hdl.handle.net/20.500.12868/256
dc.identifier.volume30en_US
dc.identifier.wosWOS:000603077400012
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthor0-belirlenecek
dc.language.isoen
dc.publisherColl Physicians & Surgeons Pakistan
dc.relation.ispartofJcpsp-Journal of the College of Physicians And Surgeons Pakistan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRenal stones
dc.subjectPotassium citrate
dc.subjectOveractive bladder
dc.titleThe effect of potassium citrate on overactive bladder disease: A cross-sectional study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu